BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35020653)

  • 1. Incidental Finding of Testicular Seminoma by 18F-Choline PET/CT in a Prostate Cancer Patient.
    Calabrò A; Bosio G; Drera E; Giubbini R; Bertagna F
    Clin Nucl Med; 2022 Mar; 47(3):e249-e251. PubMed ID: 35020653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of 18F-FDG PET/CT in Characterization of Equivocal Lesions in High-Risk Testicular Carcinoma in Restaging Setting.
    Rasheed R; Al-Kandari F; Ghanem M; Marafi F; Usmani S
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):511-515. PubMed ID: 32102532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-Fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent.
    Tilki D; Reich O; Graser A; Hacker M; Silchinger J; Becker AJ; Khoder W; Bartenstein P; Stief CG; Loidl W; Seitz M
    Eur Urol; 2013 May; 63(5):792-6. PubMed ID: 22902037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental Findings of a Vestibular Schwannoma on 18F-Choline PET/CT.
    Amrane K; Le Pennec R; Tissot V; Schick U; Abgral R
    Clin Nucl Med; 2021 Feb; 46(2):e75-e77. PubMed ID: 33234934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic Salivary Gland in a Patient With Prostate Cancer at 18F-Choline PET/CT: An Incidental Finding.
    Cuppari L; Evangelista L
    Clin Nucl Med; 2018 Aug; 43(8):593-594. PubMed ID: 29847318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.
    Rigatti P; Suardi N; Briganti A; Da Pozzo LF; Tutolo M; Villa L; Gallina A; Capitanio U; Abdollah F; Scattoni V; Colombo R; Freschi M; Picchio M; Messa C; Guazzoni G; Montorsi F
    Eur Urol; 2011 Nov; 60(5):935-43. PubMed ID: 21840116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Cancer Incidentally Detected by 18F-Choline PET/CT in a Patient With Recurrent Prostate Carcinoma.
    Vadrucci M; Gilardi L; Grana CM
    Clin Nucl Med; 2016 Nov; 41(11):892-893. PubMed ID: 27607157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental Finding on 11C-Choline-PET/CT of Hepatocellular Carcinoma Recurrence in a Prostate Cancer Patient With Negative Abdominal CT Scan.
    Guglielmo P; Pisu N; Sanna S; Pung BLJ; Boero M
    Clin Nucl Med; 2020 Sep; 45(9):703-704. PubMed ID: 32701803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of tumor recurrences after radical prostatectomy using 18F-Choline PET/CT and 3T multiparametric MRI without endorectal coil: a single center experience.
    Couñago F; Recio M; Maldonado A; Del Cerro E; Díaz-Gavela AA; Thuissard IJ; Sanz-Rosa D; Marcos FJ; Olaciregui K; Mateo M; Cerezo L
    Cancer Imaging; 2016 Dec; 16(1):42. PubMed ID: 27927229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer.
    De Leiris N; Riou L; Leenhardt J; Vuillez JP; Djaileb L
    Clin Nucl Med; 2018 Dec; 43(12):e471-e472. PubMed ID: 30300202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-positive fluorodeoxyglucose positron emission tomography results after chemotherapy in patients with metastatic seminoma.
    Decoene J; Winter C; Albers P
    Urol Oncol; 2015 Jan; 33(1):23.e15-23.e21. PubMed ID: 25454484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleural Mesothelioma Detects by 18F-Choline PET/CT in a Patient With Biochemical Recurrence of Prostate Cancer.
    Rensi M; Ferretti G; Di Gregorio F; Evangelista L
    Clin Nucl Med; 2019 Feb; 44(2):e116-e117. PubMed ID: 30516662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer.
    Goineau A; Colombié M; Rousseau C; Sadot-Lebouvier S; Supiot S
    Clin Nucl Med; 2015 Aug; 40(8):670-1. PubMed ID: 26018683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental 11C-choline PET/CT uptake due to esophageal carcinoma in a patient studied for prostate cancer.
    Bertagna F; Bertoli M; Treglia G; Manenti S; Salemme M; Giubbini R
    Clin Nucl Med; 2014 Oct; 39(10):e442-4. PubMed ID: 24561683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FACBC compared with 11C-choline PET/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28 patients.
    Nanni C; Schiavina R; Brunocilla E; Borghesi M; Ambrosini V; Zanoni L; Gentile G; Vagnoni V; Romagnoli D; Martorana G; Fanti S
    Clin Genitourin Cancer; 2014 Apr; 12(2):106-10. PubMed ID: 24135632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography for prostate, bladder, and renal cancer.
    Schöder H; Larson SM
    Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET imaging in testicular tumours.
    Calabrò D; Telo S; Ambrosini V
    Curr Opin Urol; 2020 Sep; 30(5):665-671. PubMed ID: 32732623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy for Post-Chemotherapy Residual Mass in Advanced Seminoma: A Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Risk-adapted Approach.
    Murthy V; Karmakar S; Carlton J; Joshi A; Krishnatry R; Prabhash K; Noronha V; Bakshi G; Prakash G; Pal M; Menon S; Agrawal A; Rangarajan V
    Clin Oncol (R Coll Radiol); 2021 Jul; 33(7):e315-e321. PubMed ID: 33608206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two decades of FDG-PET/CT in seminoma: exploring its role in diagnosis, surveillance and follow-up.
    Conduit C; Koh TT; Hofman MS; Toner GC; Goad J; Lawrentschuk N; Tai KH; Lewin JH; Tran B
    Cancer Imaging; 2022 Oct; 22(1):58. PubMed ID: 36209121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.